Haemonetics Corp (HAE)

78.10 +0.38 (+0.49%) USD  |  NYSE  |  Jan 08, 16:00
78.11 +0.01 (+0.01%) After-Hours: 20:00
More

Haemonetics SG&A Expense (Quarterly): 106.95M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for HAE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp 1.562B
ResMed Inc 238.98M
Globus Medical Inc 240.74M
Abbott Laboratories 2.895B
Baxter International Inc 754.00M